Today before the opening bell, Advaxis, a biotechnology company
developing the next generation of cancer immunotherapies, announced it had
signed an agreement with SynCo Bio Partners to manufacture Advaxis’ leading
drug candidate, ADXS-HPV. Under the terms of the agreement, SynCo Bio Partners
will be assisting Advaxis in development of scale-up and commercial
manufacturing processes for ADXS-HPV bulk drug substance and drug product.
As Advaxis’ lead immunotherapy for the treatment of HPV-associated
cancers, ADXS-HPV showed strong increased survival and objective tumor
responses in a Phase 2 trial featuring 110 patients with recurring cervical
cancer. In this year, Advaxis plans to begin registrational trials for patient
treatment of cervical cancer with ADXS-HPV.
“SynCo’s ability to manufacture both drug substance and drug product for
ADXS-HPV will offer us increased flexibility as we expand our manufacturing
process in preparation for commercial-scale production,” commented Daniel J.
O’Connor, Chief Executive Officer of Advaxis. “To have the support of a world-class
manufacturer, such as SynCo, is pivotal to our ability to make ADXS-HPV
available to patients on a global scale, upon approval.”
Pierre Warffemius, Chief Executive Officer of SynCo Bio Partners,
commented, “SynCo is very pleased to enter into a long-term manufacturing
collaboration and looks forward to working with Advaxis to support global
licensure of ADXS-HPV. Our leading position for supply of live microbial
biopharmaceuticals, through providing high quality manufacturing services, will
bring this therapeutic vaccine safely to patients for the treatment of
HPV-associated cancers.”
For more information, visit: www.advaxis.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment